Market closedNon-fractional
Pacific Biosciences/PACB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Pacific Biosciences
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Ticker
PACB
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Menlo Park, United States
Employees
796
Website
www.pacb.com
PACB Metrics
BasicAdvanced
$354M
Market cap
-
P/E ratio
-$1.14
EPS
1.98
Beta
-
Dividend rate
Price and volume
Market cap
$354M
Beta
1.98
Financial strength
Current ratio
9.281
Quick ratio
8.118
Long term debt to equity
143.504
Total debt to equity
143.504
Interest coverage (TTM)
-21.65%
Management effectiveness
Return on assets (TTM)
-10.84%
Return on equity (TTM)
-44.28%
Valuation
Price to revenue (TTM)
1.69
Price to book
0.55
Price to tangible book (TTM)
-1.35
Price to free cash flow (TTM)
-1.359
Growth
Revenue change (TTM)
49.54%
Earnings per share change (TTM)
-18.18%
3-year revenue growth
29.50%
3-year earnings per share growth
50.01%
What the Analysts think about PACB
Analyst Ratings
Majority rating from 14 analysts.
PACB Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$39M
-33.45%
Net income
-$78M
-4.76%
Profit margin
-201.28%
43.11%
PACB Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.28
-$0.26
-$0.31
-$0.29
-
Expected
-$0.32
-$0.33
-$0.29
-$0.28
-$0.23
Surprise
-12.67%
-20.76%
8.70%
5.31%
-
PACB News
AllArticlesVideos
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
PRNewsWire·4 weeks ago
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
PRNewsWire·2 months ago
Pacific Biosciences of California, Inc. (PACB) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pacific Biosciences stock?
Pacific Biosciences (PACB) has a market cap of $354M as of July 06, 2024.
What is the P/E ratio for Pacific Biosciences stock?
The price to earnings (P/E) ratio for Pacific Biosciences (PACB) stock is 0 as of July 06, 2024.
Does Pacific Biosciences stock pay dividends?
No, Pacific Biosciences (PACB) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Pacific Biosciences dividend payment date?
Pacific Biosciences (PACB) stock does not pay dividends to its shareholders.
What is the beta indicator for Pacific Biosciences?
Pacific Biosciences (PACB) has a beta rating of 1.98. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Pacific Biosciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.